Yoé Skincare, founded by Hazel Guo and driven by a mission to deliver true skin transformation for sensitive and autoimmune-prone complexions, has officially launched at Bloomingdale’s—both online and in select stores as of September 18, 2025. This expansion marks a breakthrough moment for the biotech-powered, science-first brand, trusting its rigorously crafted formulas to one of luxury’s most selective destinations.
Born from Guo’s own journey with autoimmune-linked skin sensitivity, Yoé is based on precise biotechnology and a relentless commitment to gentle efficacy. Each formula uses advanced encapsulated actives—like ceramides, hyaluronic acid, EGF (epidermal growth factor), niacinamide, tranexamic acid, and red algae—to deliver visible results while remaining ultra-gentle, even for those with the most fragile skin barriers.
Yoé’s “clean without compromise” promise is backed by EWG Verification™, Leaping Bunny Certification, vegan status, and a strict no-fragrance policy. According to founder Guo, “With Yoé, we set…
out to create skincare that outperforms beyond the surface, combining biotech innovation with results-driven simplicity. Our partnership with Bloomingdale’s marks an important step in sharing that vision with a wider audience of discerning clients and experts”.
Ympossible Creams: Multi-Awarded and Clinically Proven Central to the collection are the Ympossible Cream and Ympossible Cream Light, which, within a year, received the Oprah Daily Beauty O-ward, Cosmopolitan Holy Grail Award, and Women’s Health Beauty Award.
Dermatologist-tested and hypoallergenic, these creams hydrate, support barrier repair, firm skin, and visibly improve lines, texture, tone, and redness—all in a single step.
Celebrity makeup artists and estheticians rely on Yoé creams as essential skin-prep for red carpets and major events, citing instant absorption, smoothing, and the ability to prime skin for makeup flawlessly. Even beauty editors and influencers laud their efficacy in unifying routines for busy, ingredient-savvy consumers…
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.